Here you will find our prescribing guidelines including shared care guidelines and patient information leaflets.

High Cost Drugs

A number of High Cost Drugs, devices, procedures and products have been excluded from the scope of the national tariff of Payment by Results. These are listed on tab 18 of the following document:

Annex A: 2019/20 National Prices And National Tariff Workbook (608.1 KiB)

Following the re-organisation of the NHS these drugs are commissioned by:

  • NHS England or
  • Clinical Commissioning Groups

For the funding position of all CCG commissioned High Cost Drugs within the Lancashire Health Economy please download the document below:

High Cost Drugs CCG Funding Positions September 2019 Update (293.9 KiB)

The funding position of medicines directly commissioned by NHS England can be accessed via the NHS England website.

NHS England are the responsible commissioners for the management of the Cancer Drugs Fund

Refer to The Manual - for further information about prescribed specialised services, some of which are directly commissioned by NHS England and some by CCGs.